Workflow
icon
Search documents
结直肠癌药物市场扩容:靶向治疗与免疫疗法重塑百亿美元蓝海 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2025-03-19 12:00
结直肠癌药物市场扩容:靶向治疗与免疫疗法重塑百亿美元蓝海 头豹词条报告系列 摘要 结直肠癌是全球第三大常见恶性肿瘤,2023年全球患者达200万人,中国患者达53.7万人,且中晚期和转移患者众多。中国结直肠癌药物市场规模增长受发病率上升推动。 国产药企出海趋势显著,呋喹替尼成为标杆。在研管线丰富,未来更多创新疗法将驱动市场扩容。西达本胺联合信迪利单抗和贝伐珠单抗治疗结直肠癌的Ⅲ临床试验申请获 批,为MSS/pMMR晚期CRC患者提供前景治疗选择。 行业分类 结直肠癌药物种类繁多,每种药物都有其特定的作用机制和适用范围。在选择治疗药物时,医生会根据患者的具体情况(如肿瘤分期、病理 类型、基因状态等)和药物的疗效、安全性等因素进行综合考虑,为患者制定个性化的治疗方案。 按照作用机制分类 结直肠癌药物按照作用机制分类,通常包括化疗药物、靶向治疗药物、免疫治疗药物等,旨在为患者提供多种治疗选择,以应对结直肠癌 的复杂性和多样性。 化疗药物 传统化疗药物通过干扰肿瘤细胞的DNA合成或复制过程,从而抑制肿瘤细胞的生长和分裂,如氟尿嘧啶(5-FU)、奥沙利铂、伊立替康 等;口服化疗药物如卡培他滨,是氟尿嘧啶的衍生物,具有抗 ...
中国MEMS传感器行业市场规模测算逻辑模型 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2025-03-19 12:00
中国MEMS传感器行业市场规模测算 逻辑模型 头豹词条报告系列 吴明涛 中国MEMS传感器行业规模 | 1. 2018-2027年中国MEMS传感器市场规模 (结论图) | P3 | | --- | --- | | 2. 2018-2027年中国MEMS传感器市场规模 | P4 | | 3. MEMS产业市场规模(最小二乘法) | P5 | | 4. 消费者信心指数影响指标 | P6 | | 5. 数字经济核心产业专利数量影响指标 | P7 | | 6. 政策发布情况 | P8 | | 7. 增长影响率 | P9 | | 8. 溯源信息链接引用 | P10 | | 9. 法律声明 | P11 | | 10. 头豹研究院简介 | P12 | | 11. 头豹词条介绍 | P13 | | 12. 头豹词条报告 | P14 | 1. 2018-2027年中国MEMS传感器市场规模 (结论图) P3 2. 2018-2027年中国MEMS传感器市场规模 P4 2018-2027年中国MEMS传感器市场规模:(结论=A*(1+20%*E)*74%) 2018-2027年中国MEMS传感器市场规模:(结论=A*(1+20 ...
中国白芍类保健食品行业市场规模测算逻辑模型
Tou Bao Yan Jiu Yuan· 2025-03-18 12:34
中国白芍类保健食品行业市场规模 测算逻辑模型 头豹词条报告系列 胡比逊 白芍类保健食品行业规模 | 1. 中国白芍类保健食品的市场规模 (结论图) | P3 | 14. 头豹研究院简介 | P16 | | --- | --- | --- | --- | | 2. 中国白芍类保健食品的市场规模 | P4 | 15. 头豹词条介绍 | P17 | | 3. 中国总人口数量 | P5 | 16. 头豹词条报告 | P18 | | 4. 中国中老年人口比例 | P6 | | | | 5. 中国保健食品渗透率 | P7 | | | | 6. 中国白芍保健食品与整体保健食品渗透率的相对乘数 | P8 | | | | 7. 中国白芍类保健食品渗透率 | P9 | | | | 8. 中国白芍类保健食品的消费客群数量 | P10 | | | | 9. 中国白芍类保健食品人均消费频次 | P11 | | | | 10. 中国白芍类保健食品的销售数量 | P12 | | | | 11. 中国白芍类保健食品的平均价格 | P13 | | | | 12. 溯源信息链接引用 | P14 | | | | 13. 法律声明 | P15 | ...
企业竞争图谱:2025年超快激光器
Tou Bao Yan Jiu Yuan· 2025-03-18 12:10
Investment Rating - The report does not explicitly provide an investment rating for the ultrafast laser industry. Core Insights - The ultrafast laser industry is characterized by high technical barriers and strong brand and customer resource barriers, with a broad market demand expected to accelerate the replacement of traditional processing technologies. The market is anticipated to expand significantly due to supportive government policies and the development of downstream application fields [1][6][10]. Industry Definition - Ultrafast lasers refer to lasers with pulse durations shorter than nanoseconds, primarily including picosecond and femtosecond lasers. These lasers are recognized for their high instantaneous power and stable beam quality, making them suitable for various applications in medical, aerospace, consumer electronics, and precision machinery sectors [2][3]. Industry Classification - The ultrafast laser industry is classified based on the pulse width of the output laser into picosecond lasers and femtosecond lasers [3][4][5]. Industry Characteristics - The ultrafast laser industry features high technical barriers, high brand and customer resource barriers, and widespread market demand [6][10]. Development History - The ultrafast laser technology has evolved significantly since the 1960s, with key milestones including the development of the first ruby laser in China and the invention of CPA technology in the 1980s, leading to the commercialization of ultrafast lasers in the early 2000s. The industry saw a significant surge in 2020, with a near doubling of shipment volumes [11][15][14]. Industry Chain Analysis - The ultrafast laser industry chain consists of upstream raw materials (optical components, electronic components, pumping sources, and laser crystals), midstream manufacturing, and downstream applications in fields such as photovoltaic energy, medical aesthetics, and aerospace [16][19][26]. Market Size - The ultrafast laser market in China grew from 2.26 billion RMB in 2018 to 4.02 billion RMB in 2023, with a compound annual growth rate (CAGR) of 12.21%. The market is projected to reach 5.66 billion RMB by 2028, with a CAGR of 7.38% [28][29]. Future Market Drivers - The expansion of downstream application fields and the development of supporting industries are expected to drive the rapid growth of the ultrafast laser industry. The technology's advantages in precision, efficiency, and low energy consumption position it as a key player in modern manufacturing [31][32]. Competitive Landscape - The ultrafast laser industry is dominated by international players such as Coherent, IPG Photonics, and Trumpf, with a growing presence of Chinese companies like Han's Laser and Delong Laser. The competitive landscape is shaped by early market entry and technological advancements [37][38][40].
2024年制药产业全球化的路径与机遇(下):全球临床需求广阔,医保控费压力与海外定价优势共同驱动中国制药企业加速出海
Tou Bao Yan Jiu Yuan· 2025-03-18 12:01
Investment Rating - The report indicates a positive investment outlook for the Chinese pharmaceutical industry, highlighting significant growth potential and competitive advantages in the global market [5][6]. Core Insights - The globalization of China's pharmaceutical industry is driven by broad global clinical demand, cost control pressures from healthcare insurance, and pricing advantages overseas, prompting Chinese pharmaceutical companies to accelerate their international expansion [5][6][9]. - Innovative drugs, particularly in oncology and central nervous system treatments, are key focus areas for Chinese pharmaceutical companies, which are leveraging high-quality, low-cost products to gain a foothold in overseas markets [5][18]. - The aging population and increasing global life expectancy present substantial opportunities for Chinese pharmaceutical companies, especially in addressing the medication needs of elderly populations and infectious diseases in underdeveloped regions [6][8][30]. Summary by Sections Industry Overview - The Chinese pharmaceutical industry is experiencing notable growth and competitive advantages in the global commercialization process, particularly in innovative drugs like antibody therapies and cell treatments [5][6]. - The report emphasizes the importance of outsourcing clinical trials and manufacturing to experienced CXO companies to ensure international compliance [5]. Global Market Dynamics - The report highlights the increasing global demand for medications and the aging population as key factors providing development space for Chinese pharmaceutical companies [6][8]. - The focus on aging-related medications and the burden of infectious diseases in underdeveloped regions creates opportunities for the development of antibacterial and antiviral drugs [8][30]. Commercialization Strategies - Chinese pharmaceutical companies are shifting their internationalization strategies towards cell therapy, supported by chemical agents and targeted therapies, as a new commercial model [7][17]. - The report notes that the proportion of cell therapy projects in international markets has increased from 6% in 2019 to 8% in 2023, while the speed of monoclonal antibody projects has slowed [17]. Regulatory and Market Challenges - The Chinese government's healthcare cost control policies are compressing profit margins for domestic pharmaceutical companies, driving them to seek international markets as a means to alleviate cost pressures [9][40]. - The report discusses the impact of price negotiations and the need for effective sales strategies as critical challenges for Chinese pharmaceutical companies in the global market [19][40]. CXO Industry Development - The report outlines the growth of China's CXO industry, which is encouraged by government policies to enhance international cooperation and support the globalization of pharmaceutical companies [24][27]. - The increasing number of Chinese pharmaceutical companies engaging in international clinical trials and partnerships is highlighted as a significant trend [27]. Case Studies - The report provides case studies of companies like BeiGene and Yiling Pharmaceutical, showcasing their successful international strategies and product offerings in oncology and traditional Chinese medicine [48][55].
企业竞争图谱:2025年超快激光器 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2025-03-18 12:00
企业竞争图谱:2025年超快激光器 头豹词条报告系列 2025-02-21 未经平台授权,禁止转载 摘要 超快激光器是指激光脉冲持续时间更短的激光器,主要包括皮秒和飞秒激光器。该行业技术壁垒高,涉及多学科领域,且品牌及客户资源壁垒也高。随着制造业转型升级, 超快激光器市场需求广泛,将加速对传统加工技术的替代。中国出台多项政策扶持激光产业发展,形成了四大产业集群。未来,下游应用领域拓展和配套产业发展将助推激 光器产业快速发展,市场规模有望进一步扩大。 行业定义 超快激光器是指激光脉冲持续时间更短的激光器。相对纳秒激光器,超快激光器脉冲持续时间极短,瞬时功率极高,能量聚焦到极小的空间 区域且不受脉冲重复频率和平均功率影响,光束质量持续稳定。目前超快激光器主要包括皮秒激光器和飞秒激光器,以飞秒激光为代表的超快脉 冲激光技术是全球前沿激光技术之一。随着超快激光器生产工艺逐渐成熟,成本逐渐下降,未来有望广泛的应用于医疗生物、航空航天、消费电 子、照明显示、能源环境、精密机械等下游行业。 行业分类 超快激光器基于激光脉宽的分类 皮秒激光器、飞秒激光器 皮秒激光器 激光脉冲持续时间为10的-12次方秒的一种超快激光器。 飞 ...
中国白芍类保健食品行业市场规模测算逻辑模型 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2025-03-18 12:00
中国白芍类保健食品行业市场规模 测算逻辑模型 头豹词条报告系列 | 年份 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | 2026E | 2027E | 2028E | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 数据(个) | 0.09 | 0.09 | 0.09 | 0.09 | 0.1 | 0.1 | 0.11 | 0.11 | 0.11 | 0.11 | 中国白芍类保健食品的平均价格:I 胡比逊 白芍类保健食品行业规模 | 1. 中国白芍类保健食品的市场规模 (结论图) | P3 | 14. 头豹研究院简介 | P16 | | --- | --- | --- | --- | | 2. 中国白芍类保健食品的市场规模 | P4 | 15. 头豹词条介绍 | P17 | | 3. 中国总人口数量 | P5 | 16. 头豹词条报告 | P18 | | 4. 中国中老年人口比例 | P6 | | | | 5. 中国保健食品渗透率 | P7 | | | | 6 ...
商用车系列:2024年中国商用车企业竞争格局判断报告:尾部企业淘汰赛加速
Tou Bao Yan Jiu Yuan· 2025-03-17 12:12
Investment Rating - The report indicates a competitive landscape in the Chinese heavy truck market, suggesting an acceleration in the elimination of tail-end enterprises [1]. Core Insights - The heavy truck market in developed countries has entered a mature phase, with the U.S. experiencing a gradual decline in economic growth momentum and Japan and Germany showing stable but low growth in heavy truck sales [3][4][5]. - China's heavy truck market is undergoing a critical transformation, with a shift from an incremental growth model to a focus on stock replacement, leading to increased competition among enterprises [3][6]. Summary by Sections U.S. Heavy Truck Market - The U.S. heavy truck market shows signs of maturity, with economic growth slowing from an average of 8.0% (1970-2002) to 3.1% (2008-2020) [7]. - Heavy truck ownership correlates with GDP growth, but is subject to fluctuations due to global events [7][8]. German and Japanese Heavy Truck Markets - Both Germany and Japan exhibit characteristics of mature markets, with significant declines in heavy truck sales linked to economic stagnation [12][13]. - The average scrapping cycle for heavy trucks in Germany is 8-10 years, influenced by global public health events [13]. Chinese Heavy Truck Market - China's heavy truck ownership is closely tied to economic development, with a recent phase of oversupply due to declining GDP growth rates [17]. - The market is transitioning to a stock replacement model, with heightened sensitivity to standard changes and intensified competition among enterprises [17][20]. Price Competition in the Heavy Truck Market - A price war is evident in the heavy truck sector, driven by industry downturns and standard changes, with significant price reductions observed in both fuel and electric models [20][22]. - The average price of heavy trucks has seen notable declines, with some models experiencing discounts of up to 50,000 yuan [22]. Tail-End Enterprises Comparison - Among tail-end enterprises, XCMG leads in sales with 3,110 units, followed by Beiben and Dayun with 638 and 586 units respectively [25]. - In terms of production capacity, Jianghuai leads with 1.017 million units, while other companies like Dayun and XCMG have significantly lower capacities [25].
智能交互的伦理边界与商业想象:AIGC聊天机器人:对话未来革命
Tou Bao Yan Jiu Yuan· 2025-03-17 12:03
Investment Rating - The report does not explicitly provide an investment rating for the AIGC chatbot industry Core Insights - The AIGC chatbot industry is experiencing rapid growth since the launch of ChatGPT in 2022, with diverse applications across various sectors such as smart homes, social media, e-commerce, education, healthcare, and enterprise services. The industry is characterized by high investment and high barriers to entry, leading to a concentration of resources among leading companies, resulting in a monopolistic competition landscape. The market is expected to continue expanding over the next decade [1] Industry Definition - AIGC chatbots are computer programs that simulate human language interaction through text, voice, or multimodal forms. Unlike traditional chatbots that rely on preset rules, AIGC chatbots utilize generative AI technologies, particularly the Transformer architecture, to provide personalized and adaptive interaction experiences [2] Industry Characteristics - The AIGC chatbot industry is defined by several key characteristics: diverse usage scenarios, technology-driven development, high investment requirements, high entry barriers, regional concentration, and policy-driven growth [8] Market Growth and Forecast - The AIGC chatbot market is projected to grow from 2.5 billion RMB in 2024 to 61.42 billion RMB by 2029, with a compound annual growth rate (CAGR) of 89.58% [36] - The global generative AI market is expected to grow from 40 billion USD to 1.3 trillion USD over the next decade, indicating significant growth potential [39] Industry Development Stages - The AIGC chatbot industry has evolved through four main stages: initial stage (1960s), language introduction stage (1990s), deep learning stage (early 2000s), and the generative AI stage (2020s) [15] Industry Chain Analysis - The AIGC chatbot industry chain consists of upstream (chip manufacturing and data services), midstream (algorithm models and technical frameworks), and downstream (applications in various sectors) [21] - The industry is witnessing a trend towards domestic production in the supply chain, particularly in chip manufacturing and algorithm framework development, driven by international restrictions and market demand [22] User Experience and Application Scenarios - AIGC chatbots enhance user experience by providing high-quality dialogue capabilities, applicable in customer service, financial interactions, healthcare consultations, educational support, and creative industries [34] Regional Development - The development of the AIGC chatbot industry shows significant regional characteristics, with major advancements in areas like Beijing, Shanghai, and Guangdong, which benefit from strong financing capabilities, talent pools, and policy support [13] Policy Support - The industry is supported by a multi-level policy framework that promotes AI technology application in various sectors, emphasizing the importance of AIGC in enhancing economic quality [14]
商用车系列:2024年中国商用车企业竞争格局判断报告:尾部企业淘汰赛加速(精华版)
Tou Bao Yan Jiu Yuan· 2025-03-17 11:51
头豹市场研究| 2024/12 商用车系列: 2024年中国商用车企业竞争格局判断 报告:尾部企业淘汰赛加速 2024 China Heavy Truck Market Cyclical Study 2024 年中国大型トラック市場の循環的研究 (精华版) 报告标签:重卡、自卸车、房地产、牵引车、商用车、GDP 撰写人:马天奇 报告提供的任何内容(包括但不限于数据、文字、图表、图像等)均系头豹研究院独有的高度机密性文件 (在报告中另行标明出处者除外)。未经头豹研究院事先书面许可,任何人不得以任何方式擅自复制、再 造、传播、出版、引用、改编、汇编本报告内容,若有违反上述约定的行为发生,头豹研究院保留采取法 律措施、追究相关人员责任的权利。头豹研究院开展的所有商业活动均使用"头豹研究院"或"头豹"的商号、 商标,头豹研究院无任何前述名称之外的其他分支机构,也未授权或聘用其他任何第三方代表头豹研究院 开展商业活动。 www.leadleo.com 头豹市场研读 | 2024/12 观点摘要 从国际经验看,主要发达国家重卡市场已全面进入成熟期:美国1970-2020年经历六个完整 经济周期,虽然销量中枢整体呈上移趋势 ...